Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Sekisui XenoTech Introduces Lysosomal Test Systems for Biopharmaceutical Development

    Oct 5, 2016, 09:56 AM by Michael Croft
    KANSAS CITY, KS, UNITED STATES - Oct 5, 2016 - Sekisui XenoTech now offers hepatic human lysosomes and rat tritosomes as standard test systems. These products contain high concentrations of lysosomal degradative enzymes and constitute advantageous test systems for analysis of catabolism and/or activation for targeted biopharmaceuticals that enter cells through the endosomal-lysosomal pathway
    Full story
  • Rumors, Expectations Surround Apple Expansion Into Health Care

    Oct 5, 2016, 09:15 AM by Michael Croft
    POLITICO | The tech giant is cementing partnerships with big health systems and hiring scores of health care professionals.
    Full story
  • The International Biomedical Research Alliance Appoints Life Sciences Patent Lawyer to its Board

    Oct 5, 2016, 08:38 AM by Michael Croft
    BETHESDA, MD - Oct 5, 2016 - The International Biomedical Research Alliance, a non-profit organization which provides programming and funding support for the National Institutes of Health (NIH) Oxford-Cambridge Scholars Program, today announced that Jeffrey I
    Full story
  • Gene Editing Takes the Stage at Discovery on Target 2016

    Oct 5, 2016, 07:00 AM by Michael Croft

    Bio-IT World | In the Advances in Gene Editing, Gene Silencing, and Gene Therapy Tracks at the 2016 Discovery on Target conference, we heard from researchers on their exciting new advancements in CRISPR-CAS9 and beyond. The implications for cancer, anti-viral therapies, genetic diseases, and organ transplantation are vast.

    Full story
  • Recipharm launches serialisation showcase line

    Oct 5, 2016, 04:22 AM by Michael Croft
    FONTAINE, FRANCE - Oct 3, 2016 - Recipharm, the contract development and manufacturing organisation (CDMO), has launched a showcase line for serialisation, offering pharmaceutical companies the chance to view and trial its solution to the new European and US regulations
    Full story
  • Azure is becoming the first AI supercomputer says Microsoft

    Oct 4, 2016, 15:34 PM by Michael Croft
    ZDNet | Microsoft's CEO on how its cloud computing service is evolving.
    Full story
  • Anti-Aging Through Regenerative Medicine

    Oct 4, 2016, 14:17 PM by Michael Croft
    CRYSTAL LAKE, IL, UNITED STATES - Oct 4, 2016 - Treatments utilizing regenerative medicine cause our body’s natural healing processes to work both more effectively and rapidly
    Full story
  • TARGET PharmaSolutions Announces the Launch of TARGET-PBC (Primary Biliary Cholangitis)

    Oct 4, 2016, 12:43 PM by Michael Croft
    CHAPEL HILL, NC, UNITED STATES - Oct 3, 2016 - TARGET PharmaSolutions, Inc. is pleased to announce the launch of TARGET-PBC (Primary Biliary Cholangitis)
    Full story
  • Biotech PR Needs to Deliver More Signal Less Noise

    Oct 4, 2016, 10:49 AM by Michael Croft
    Forbes | It's hard to know how to get attention for your news these days. The Cambrian explosion of information on the Internet over the past decade has created a confusing world. PR firms have stepped right up to help biotech companies navigate it.
    Full story
  • Genedata Screener 14 Raises the Bar on Efficiency and Workflow Support

    Oct 4, 2016, 10:14 AM by Michael Croft
    BASEL, N/A, SWITZERLAND - Oct 4, 2016 - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced Genedata Screener® version 14
    Full story
  • STERLING PHARMA SOLUTIONS LAUNCHES FOLLOWING MANAGEMENT BUYOUT

    Oct 4, 2016, 05:47 AM by Michael Croft
    DUDLEY, UK - Oct 3, 2016 - UK-based Sterling Pharma Solutions has formed as an independent contract development and manufacturing organisation (CDMO) following a management buyout (MBO) of the UK based Dudley site
    Full story
  • BARDA Awards Contract to DNAe to Develop Semiconductor DNA Sequencing Platform

    Oct 3, 2016, 14:30 PM by Michael Croft

    Bio-IT World Brief | DNAe announced that BARDA has awarded the company a contract worth up to $51.9 million to develop its sequencing platform for rapid diagnosis in two key applications; antimicrobial resistant infections and influenza.

    Full story
  • H1N1 Vaccination Market is Anticipated to Boost in Focus period due to Rising Cases of Swine Flu

    Sep 30, 2016, 08:34 AM by Michael Croft
    ALBANY, NY, UNITED STATES - Sep 30, 2016 - H1N1 influenza virus or swine H1N1 virus is a causative agent of infectious disease caused in human beings known as H1N1 or commonly referred as swine flu
    Full story
  • Kidney Function Tests Market Propelled by Increasing Incidence of Kidney Damage

    Sep 30, 2016, 06:19 AM by Michael Croft
    ALBANY, NY, UNITED STATES - Sep 30, 2016 - Kidneys are among the most vital organs of the human body. Kidneys acts as blood filters, reabsorbing the essential elements and removing the water-soluble waste products from the blood
    Full story
  • High Demand for Radiation-Free Ultrasound to Dominate Ophthalmic Ultrasound System Market’s Future

    Sep 30, 2016, 04:19 AM by Michael Croft
    ALBANY, NY, UNITED STATES - Sep 30, 2016 - Ultrasound systems have become as indispensable in the field of ophthalmology as standard clinical assessment modalities such as slit lamp or indirect ophthalmoscopy, the standard means for evaluating the anterior segment of the retina
    Full story
  • Quertle releases Qinsight — a biomedical literature discovery product built on its BioAI artificial intelligence platform

    Sep 29, 2016, 18:35 PM by Michael Croft
    HENDERSON, NV, UNITED STATES - Sep 29, 2016 - Henderson, Nevada-based Quertle LLC, developer of the first artificial intelligence (AI) biomedical big data platform (BioAI™), has released Qinsight™
    Full story
  • Oxford Nanopore’s Plans for Pre-Packaged Cas9 Test Kits

    Sep 29, 2016, 16:35 PM by Michael Croft

    Bio-IT World | Oxford Nanopore Technologies is seeing more of a demand to focus on a subset of input materials, Clive Brown said this morning in his technical update. In addition to new pores, new chemistries, and updates on various devices, Brown dove into a Cas9 application that the company has been exploring and intimated that Oxford Nanopore will soon begin selling specific test kits for its mobile sequencers.

    Full story
  • Oxford Nanopore Announces New Pores, Kits and Updates on Projects

    Sep 29, 2016, 13:45 PM by Michael Croft
    Bio-IT World | The Chief Technology Officer at Oxford Nanopore gave a technical Oxford Nanopore update this morning, outlining updates on MinION, PromethION, SmidgeION, hardware and chemistries. 
    Full story
  • Cloud Pharmaceuticals, Rubicon Genomics, Bioz and more: News from September 2016

    Sep 29, 2016, 11:05 AM by Michael Croft
    Bio-IT World News Briefs | News, products, and partnerships from around the bio-IT community including news from Cloud Pharmaceuticals, Rubicon Genomics, Bioz, and more.
    Full story
  • SANECA PHARMA INVESTS IN SMALL SCALE API CAPABILITIES

    Sep 29, 2016, 10:26 AM by Michael Croft
    HLOHOVEC, SLOVAKIA - Sep 29, 2016 - CONTRACT development and manufacturing organisation (CDMO) Saneca Pharma is investing heavily in its API capabilities to support client demand for smaller batch sizes and streamlined scale-up
    Full story
  • «
  • 331
  • 332
  • 333
  • 334
  • 335
  • 336
  • 337
  • 338
  • 339 (current)
  • 340
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy